9999999997-13-013990.txt : 20130916 9999999997-13-013990.hdr.sgml : 20130916 20130916140455 ACCESSION NUMBER: 9999999997-13-013990 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20130916 DATE AS OF CHANGE: 20130916 20130916 20130916 FILER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 131098420 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER RD CITY: TARRYTOWN STATE: NY ZIP: 10591-6707 BUSINESS PHONE: 9143477000 CT ORDER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"C4Q(#`@;V)J#3P\+TQI;F5AF4@-C0O5'EP92]84F5F+U=;,2`R(#%=/CYS=')E86T-"FC>8F)D$&!@ M8F#R`A(,4X`$XPT@P1(!)-A;@,2G2PQ,C`R'0+(,C.C$?\:)?P`"#`#65P?D M#0IE;F1S=')E86T-96YD;V)J#7-T87)T>')E9@T*,`T*)25%3T8-"B`@("`@ M("`@#0HV,R`P(&]B:@T\/"]#(#8Y+T9I;'1E8F!@8&%@8(IF``*>:PRH@)$! M),O1@"S&`L4,##<8N!FXF,-8%D"5RIV$T$P[D14;;H6(,LH!!!@`+*4&<0T* M96YD7!E+U!A9V4^/@UE;F1O8FH--30@,"!O8FH-/#PO1FEL=&5R+T9L871E M1&5C;V1E+T9I[3= M9KNM-FV6%Z7ZVU. M&)VW^>X;X8FFBY>G''T!52&6NKER=4#>X'-O]8[FL5D6YIO=% M>5TV17B?%7733C=9[;;]@U"*SI]_M`!G43_GB"N`[D%)Z>^[%.*9P#&-$!C(:%`'B"W0>])2&/88,X?9HP M8H1P0V;PZ=>:\P`RL2GZPAILJ92=+[Q[/_>NW"3'>;"0.&D2%:4L#\`0I`N6 M+K%_QOH0TZ]MO_;V$..`)I$-0?4-0'LJB1`,GPJ>JF^.BG#X$X@[UREH``##QDWTDQ`N`%P'H,1KK=O,T,.BP.=#)%>^*;:EP3 MY("LTW?Q1@VBHD,:2SA!'(E(L)!(0M"!&0>P?D3&`N,33O*`@`\T:2PP!;&$ M23B41Z9[DQ)DB'E$6@KTZSCV+^E7[],O,^?1[YO,*X\PKV6GB5?:D\1[)N>Z MC]I_S+F2#?0)C`(V;D=76\TXT+U2+BU9_!MA,#`/S>CPQAXW2F^E2K9YUO^ MFF]E=$1C@4+]US>6D+.78_'8?GT\OZ>]0Y0*`GO_,=T>$T^WQ\71[6\!!@!T M-GQV#0IE;F1S=')E86T-96YD;V)J#34U(#`@;V)J#3P\+T9I;'1E&QQY:[R:HBZ(&M.8Q M',[QS<&WHY.S&_;Z]=GUX.J<1>S-F[?G`W9R-KB+V.P1%MCC;'MR-AI%3++1 MAQ.I6!C!,OS/(Y9%/9&G;+0YX2P8_7YR<8UG"W[2\9,]%DHA$S::/T.J'&GD M*,^?H=2>4D219J,92&1&3RS4(L^+J\;\79#P(?RN`L5'%^F M1#&L*=.L0N)42$62UZ2-^2*(^3T.]H&&"?#?!%+SJ=M[@!^3Z2E3D=1T7T_H MM,UDJ3>94J(;!UF+A1.1)V6)2>O;<[+2+4.#W?;!N1$?%G8F.S):-78<7@:Y MV3('2[3]'\G>M'`+FS+A?9J@V1UQU<8J%E'>IGZO#3%P6E?0.G3*T+6$!(.! M+X22@=$QA/H#(F=D`30`DT&H>(X?C9_X6*]$MNF5>[UT)%32Y5895>P0.SO$ M>)F,1!Z7[7"+(BT^$NBVB/O%PPXG-#;.O`DROL3I!#<>:&T#BL%4QGRV..#> M'B:2K]`T,Z);X_`137&*4W:%0^(Z$S4+0#3+5@M(G]W"3$3=%O`9+H3(JZA[ M&1@I%9X6K(_T\ODXS(4J913^6]-?"R.?7*'<2%-N M0JE$9DRK6TSK<]KHV[*J59194Q&Z,D172N`"M"P0/MPA#(Q_@XA8XG!"P*+] M#6)G0LC"]`@3`RRBF-211:M7@,87QKM5/+.&(]+?IAN$`0$A[W_(";F M;`+?+7WO[^F"M2>=!2AL;*AI9;=EARU=VF",,9]3=)%FK%XX;E$>$##Q-CL4 MR%3QU*#28DR[*%',@-*FN;#(&#Y;IANV7=@^2KC;'<&6%-7R*@STJQ/9( MS?`N=AGTO$";NLT1N3(J8E?ZV![SG\WMNI8CY@Q<3&S&O$^&1$A\1`$.!"7" M`H-B31N^8G-!%T0B;:U)563\PZ9<63Z'!?@<+@MII,<`& M3;`D4>\Y,)B^#^!+PYB&-C;IZ)+2ZWE@.?])7PH&=Y,1CWCN4)Y[^AX)A.K1 M>$L%8^:T9$L?@\9&$*A@Q84[;QI\JZ9A8&)UNS.IA+X[=G^85@L/S6PHHCKS M0G2_O?-AS8K:)IBU'A72V&AE3F^+;`;GI>5_2JL,V7RBH>=_F!M9S6'RF]5% M-O@,]W';^KUD_\(PQ&/M4^[NR7EF2U*5A%C2\M3JA0Q2D2L;Y^#M:J_V:.*HG5O"D:/:M5Z MA1%:K9@%Z7ZU\4=#C0E`-:6` M5S4YH'./6RM;\2C30)MW5C;_V(GJI!7IFR9C>(').DQZMC1##4Y(]A@?0*7# M8,BTD9D!*B'W0"AE.L=>B]@]_MD>J M:M83T'A;7J>5KGA/I>]?[RI.H1_``^;U.O%]N^L6C+QH9.S%I$1Y2[T8E6W[ MI@&.Y.5)N2,QS]Z#@0*)YOH':@JL-9X8-,8]Z\=7QNBJ]7VC8N_73.19IUN3 M([<>D:3=),\^DO[QQ(1>T9C]14\7,-W4-WA+1AE3F'_DM?NE18Q)F6E[RNR5 M0R']^O3066T:.GZGW1UV*XL9M?N+O5'.OM,@\#_7PD*+K->J2EZH(I&VP_TZ MZO2MEMTDJIOD.'TCBY,HDP,"0FU=2Y![D&!D1 M&:7`?IZ!C8&9`0P2DXL+'`,"?$#LO/R\5`8,\.T:`R.(OJP+,@M3'B]@32XH M*@'2!X#8*"6U.!E(?P'BS/*2`J`X8P*0+9*4#6:#U(EDAP0Y`]D=0#9?26H% M2(S!.;^@LB@S/:-$P=#2TE+!,24_*54AN+*X)#6W6,$S+SF_J""_*+$D-06H M%FH'"/"[%R56*K@GYN8F*ACI&9'H9+;;]J'##_1A]\8>Y\0^MENJ*5(22B0Q4";)-86: MFM12")0:H<"4,"`(9?R"4E9$0SDB,*JND1$IR(1LD1F9A1BPP,B`!(L9F91X MP8+!BM26N$'&2`R>U(D8/)%,#)[$FA@\K0,)>"I,`I[B.W@,FI663S>`"'A- MTY*`UZ1(`EX;EK4A%:L#KTTU5HDI8WT*7E0F!2]B/7@,J59:5I@`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`@("`@("`@/'AM<#I#&UP34TZ&UP34TZ&UL;G,Z<&1F>#TB:'1T<#HO+VYS+F%D;V)E M+F-O;2]P9&9X+S$N,R\B/@H@("`@("`@("`\<&1F>#I3;W5R8V5-;V1I9FEE M9#Y$.C(P,3,P.3$V,38U.30Q/"]P9&9X.E-O=7)C94UO9&EF:65D/@H@("`@ M("`@("`\<&1F>#I#;VUP86YY/E-E8W5R:71I97,@86YD($5X:&%N9V4@0V]M M;6ES#I#;VUP86YY/@H@("`@("`@("`\<&1F>#I#;VUM96YT M#I#;VUM96YT7!E+T]B:E-T;3X^V@2]4-)B*(TY."(.BY6Z,6L9&T!7U[._'@R5L(__\E M)0+"?%XL8[BR9-'GQ8KO=W+!9T<2;]F!&N%G^]#NE1VHBV*#)0_:&5@_K]I= M"/J2]7T\185T2%.C`V7-;(QJ@K6JU*2LQ]40IP/$P3>53BX[X58'V#>;G;Z1 M@,*1@C,+G%A,7NS8_(?VPB9VE"3#+?4.;&TK6EX]E5X_<)2.DF//ELPO5)7U M5.6+Q5N``0!..T\<#0IE;F1S=')E86T-96YD;V)J#34@,"!O8FH-/#PO1&5C M;V1E4&%R;7,\/"]#;VQU;6YS(#0O4')E9&EC=&]R(#$R/CXO1FEL=&5R+T9L M871E1&5C;V1E+TE$6SQ#.$8Y1D$R13%",S7!E+UA2968O M5ULQ(#(@,5T^/G-T-05P&QN%&,%T#$HP,``$&`/QO!6T-"F5N9'-T